{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:21:25Z","timestamp":1792592485730,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Ejection fraction preserved heart failure (HFpEF) is a common clinical syndrome with a high morbidity, accounting for ~50% of all heart failure patients, and a mortality comparable to that of ejection fraction reduced heart failure (HFrEF). The relationship between liver stiffness (LS) and HFpEF remains unclear. The purpose of this study was to explore the correlation between LS and the severity of HFpEF.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We performed a prospective observational study. After accepting liver transient elastography on admission, consecutive 150 hospitalized HFpEF patients were divided into three groups based on their liver elasticity value: first-third quartiles. Left ventricular diastolic function, left ventricular hypertrophy degree, right cardiac function and short-term prognosis (\u22641 year) were compared among the three groups, and the correlation between liver elasticity and each indicator was analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The elasticity of the liver was abnormally high in more than two-thirds of cases. The proportion of NYHA class III-IV in the third quartile group was significantly higher than that in the first quartile group (96 vs. 70%, <jats:italic>P<\/jats:italic> = 0.013). Significant differences were discovered in the level of lgNT-proBNP between the three groups (2.63 \u00b1 0.65 vs. 2.84 \u00b1 0.44 vs. 3.05 \u00b1 0.71, <jats:italic>P<\/jats:italic> = 0.027). In terms of diastolic function and left ventricular hypertrophy, the ventricular septal e\u2032 (5.01 \u00b1 2.69 vs. 6.48 \u00b1 2.29, <jats:italic>P<\/jats:italic> = 0.025), lateral wall e\u2032 (6.63 \u00b1 3.50 vs. 8.62 \u00b1 2.73, <jats:italic>P<\/jats:italic> = 0.013), mean E\/e\u2032 (20.06 \u00b1 7.53 vs. 13.20 \u00b1 6.05, <jats:italic>P<\/jats:italic> = 0.001), left atrial volume index (43.53 \u00b1 10.94 vs. 35.78 \u00b1 13.86, <jats:italic>P<\/jats:italic> = 0.008), tricuspid regurgitation (TR) peak flow rate (3.16 \u00b1 0.44 vs. 2.75 \u00b1 0.50, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), left ventricular mass index (LVMI) in male (163.2 \u00b1 47.6 vs. 131.3 \u00b1 38.0, <jats:italic>P<\/jats:italic> = 0.015) and in female (147.4 \u00b1 48.6 vs. 110.6 \u00b1 24.3, <jats:italic>P<\/jats:italic> = 0.036) was significantly different between the third quartile and the first quartile. The proportion of patients with diastolic dysfunction in the third quartile was significantly higher than that in the first quartile (70 vs. 36%, <jats:italic>P<\/jats:italic> = 0.017). In terms of right cardiac function, right ventricular fractional area change (RVFAC) (30.3 \u00b1 5.4 vs. 36.5 \u00b1 6.8, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), tricuspid annular plane systolic excursion (TAPSE) (7.7 \u00b1 5.2 vs. 14.8 \u00b1 5.9, <jats:italic>P<\/jats:italic> = 0.010), pulmonary systolic pressure (38.0 \u00b1 10.5 vs. 32.4 \u00b1 10.3, <jats:italic>P<\/jats:italic> = 0.005), TR peak flow rate (3.16 \u00b1 0.44 vs. 2.75 \u00b1 0.50, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), and inferior vena cava diameter (2.53 \u00b1 0.51 vs. 1.98 \u00b1 0.41, <jats:italic>P<\/jats:italic> &amp;lt; 0.001) were significantly different between the third quartile and the first quartile. More than half of HFpEF patients were combined with right ventricular dysfunction (RVD). Compared to HFpEF without RVD, HFpEF with RVD had higher male sex (53.6 vs. 30.3%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), higher NYHA class (3.2 \u00b1 0.6 vs. 2.8 \u00b1 0.6, <jats:italic>P<\/jats:italic> = 0.010), higher proportion of atrial fibrillation (45.2 vs. 18.2%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), and higher liver elasticity value (7.95 \u00b1 0.60 vs. 7.31 \u00b1 0.84, <jats:italic>P<\/jats:italic> = 0.003). In terms of short-term prognosis, the incidence of adverse cardiovascular events was significantly higher in the third quartile than in the first quartile (<jats:italic>P<\/jats:italic> = 0.003) and the second quartile (<jats:italic>P<\/jats:italic> = 0.008). Multivariate Cox proportional hazard analysis showed that adverse cardiovascular events were independently associated with NYHA class, atrial fibrillation, lgNT-proBNP and liver elasticity value (HR = 1.208, 95% CI 1.115\u20131.352, <jats:italic>P<\/jats:italic> = 0.002).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Increase of liver stiffness is common in HFpEF patients. Increased LS in HFpEF patients was significantly associated with worsen left diastolic function, left ventricular hypertrophy, and the right cardiac function. LS in HFpEF patients may be more than the result of right ventricular dysfunction. Male, atrial fibrillation, poorer NYHA class and increased liver elasticity value were significantly associated with HFpEF combined with RVD. Atrial fibrillation, poorer NYHA class, higher NT-proBNP, and increased liver elasticity value were independent predictors of poor short-term prognosis of HFpEF patients.<\/jats:p>","DOI":"10.3389\/fcvm.2021.748173","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:50:31Z","timestamp":1638316231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure"],"prefix":"10.3389","volume":"8","author":[{"given":"Junyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","article-title":"Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies","volume":"115","author":"Sharma","year":"2014","journal-title":"Circ Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1253\/circj.CJ-08-1073","article-title":"Heart failure with preserved ejection fraction","volume":"73","author":"Yamamoto","year":"2009","journal-title":"Circ J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/eurheartj\/ehu067","article-title":"Heart failure with preserved ejection fraction: a clinical dilemma","volume":"35","author":"Komajda","year":"2014","journal-title":"Eur Heart J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cardfail.2016.01.011","article-title":"Optimizing the management of heart failure with preserved ejection fraction in the elderly by targeting comorbidities (OPTIMIZE-HFPEF)","volume":"22","author":"Fu","year":"2016","journal-title":"J Card Fail."},{"key":"B6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J Card Fail."},{"key":"B7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1053\/jhep.2003.50062","article-title":"Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations","volume":"37","author":"Myers","year":"2003","journal-title":"Hepatology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jchf.2013.10.006","article-title":"Developing therapies for heart failure with preserved ejection fraction: current state and future directions","volume":"2","author":"Butler","year":"2014","journal-title":"JACC Heart Fail."},{"key":"B9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10741-013-9405-8","article-title":"Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target","volume":"19","author":"Glezeva","year":"2014","journal-title":"Heart Fail Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/CIRCHEARTFAILURE.113.000823","article-title":"Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives","volume":"7","author":"Guazzi","year":"2014","journal-title":"Circ Heart Fail."},{"key":"B11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1478-3231.2005.01238.x","article-title":"The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis","volume":"26","author":"Adams","year":"2006","journal-title":"Liver Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MCO.0b013e32832c7819","article-title":"The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis","volume":"12","author":"Lanthier","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.ultrasmedbio.2015.03.007","article-title":"WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 3: liver","volume":"41","author":"Ferraioli","year":"2015","journal-title":"Ultrasound Med Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0735-1097(88)80060-3","article-title":"Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults","volume":"12","author":"Daniels","year":"1988","journal-title":"J Am Coll Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ejhf.1029","article-title":"Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Gorter","year":"2018","journal-title":"Eur J Heart Fail."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: an overview and clinical implications","volume":"61","author":"Samsky","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ajg.2012.362","article-title":"Cardiovascular risk factors and systemic endothelial function in patients with cirrhosis","volume":"108","author":"Berzigotti","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0002-9149(03)00370-9","article-title":"Liver dysfunction and heart failure","volume":"91","author":"Cogger","year":"2003","journal-title":"Am J Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"M\u00f8ller","year":"2013","journal-title":"Eur Heart J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.ultrasmedbio.2018.07.008","article-title":"Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations","volume":"44","author":"Ferraioli","year":"2018","journal-title":"Ultrasound Med Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jhep.2007.11.020","article-title":"Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome","volume":"48","author":"Roulot","year":"2008","journal-title":"J Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/eurjhf\/hfs044","article-title":"Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography","volume":"14","author":"Hopper","year":"2012","journal-title":"Eur J Heart Fail."},{"key":"B27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1148\/radiol.10100013","article-title":"Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography","volume":"257","author":"Colli","year":"2010","journal-title":"Radiology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1253\/circj.CJ-14-0929","article-title":"Novel method of evaluating liver stiffness using transient elastography to evaluate perioperative status in severe heart failure","volume":"79","author":"Nishi","year":"2015","journal-title":"Circ J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jcmg.2017.10.022","article-title":"Liver stiffness reflecting right-sided filling pressure can predict adverse outcomes in patients with heart failure","volume":"12","author":"Taniguchi","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11897-013-0166-4","article-title":"Ventricular remodeling in heart failure with preserved ejection fraction","volume":"10","author":"Shah","year":"2013","journal-title":"Curr Heart Fail Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.jacc.2012.08.004","article-title":"Endothelial dysfunction: a pathophysiologic factor in heart failure with preserved ejection fraction","volume":"60","author":"Lam","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/j.1478-3231.2012.02814.x","article-title":"ADMA and hepatic endothelial dysfunction in cirrhosis\u2013the DDAH isoform is the key","volume":"32","author":"Mookerjee","year":"2012","journal-title":"Liver Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1161\/CIRCULATIONAHA.114.013536","article-title":"It is time to look at heart failure with preserved ejection fraction from the right side","volume":"130","author":"Chatterjee","year":"2014","journal-title":"Circulation."},{"key":"B34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.114.001583","article-title":"Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Heart Fail."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1093\/eurheartj\/ehu193","article-title":"Right heart dysfunction in heart failure with preserved ejection fraction","volume":"35","author":"Melenovsky","year":"2014","journal-title":"Eur Heart J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9149(02)02886-2","article-title":"Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation","volume":"90","author":"Lau","year":"2002","journal-title":"Am J Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.amjcard.2015.11.030","article-title":"Relation of tricuspid regurgitation to liver stiffness measured by transient elastography in patients with left-sided cardiac valve disease","volume":"117","author":"Chen","year":"2016","journal-title":"Am J Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/CIRCULATIONAHA.109.887570","article-title":"Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure","volume":"121","author":"Meyer","year":"2010","journal-title":"Circulation."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/j.jacc.2013.02.049","article-title":"Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure)","volume":"61","author":"Damy","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1161\/CIRCULATIONAHA.110.985515","article-title":"Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study","volume":"123","author":"Kawut","year":"2011","journal-title":"Circulation."},{"key":"B41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4103\/2045-8932.101647","article-title":"Testosterone negatively regulates right ventricular load stress responses in mice","volume":"2","author":"Hemnes","year":"2012","journal-title":"Pulm Circ."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.748173\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:50:36Z","timestamp":1638316236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.748173\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":41,"alternative-id":["10.3389\/fcvm.2021.748173"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.748173","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"article-number":"748173"}}